SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    -50.00 (-1.11%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Update

18 Nov 2024 07:00

RNS Number : 5845M
Judges Scientific PLC
18 November 2024
 

Press Release

18 November 2024

 

Judges Scientific plc

 

("Judges Scientific" or the "Company")

 

Trading Update

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, today provides an update on trading.

 

As announced at the time of the Group's Interim Results in September, several of our Group businesses had experienced a challenging first half, driven by difficult market conditions and the deferral of some projects into H2 or 2025. We expected the second half to show significant improvement, with a number of agreements signed too late to impact the first half but contributing to the second, in addition to the signature of a 2025 coring contract.

 

As anticipated, H2 will show progress compared to H1. However, achievement of the expectations for the full year, which were revised downwards in July, was reliant upon the crystallisation and delivery of certain orders. We now believe these will not all occur in time to deliver against the expectations before the end of the year.

 

Organic order intake YTD to the end of October has progressed 4.2% vs 2023 including a coring contract by Geotek. Order intake would be 1.6% down if we excluded this contract, indicating that the general level of orders across the Group has not yet recovered to the growth path traditional for our Group.

 

As a result, the Board now expects Adjusted basic earnings per share for the year to 31 December 2024 to be between 270p and 300p.

 

In spite of the disappointing trading performance, the Board is confident that the long-term growth drivers of our business remain solid.

 

 

For further information please contact: 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000

Alma (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIILRLDLIS
Date   Source Headline
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker
31st Mar 20238:54 amRNSGrant of Options
22nd Mar 20237:00 amRNSFinal Results
8th Mar 20232:39 pmRNSTotal Voting Rights
8th Mar 20237:00 amRNSDirector/PDMR Shareholding
13th Feb 20238:48 amRNSDirector/PDMR Shareholding
2nd Feb 20239:17 amRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSExecutive Director and Board Appointment
1st Feb 20237:00 amRNSTotal Voting Rights
23rd Jan 202310:27 amRNSGrant of Options
19th Jan 20237:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20231:03 pmRNSTotal Voting Rights
21st Dec 202210:51 amRNSBlock listing Interim Review
20th Dec 202211:53 amRNSDirector/PDMR Shareholding
12th Dec 20228:52 amRNSHolding(s) in Company
6th Dec 20222:34 pmRNSDirector/PDMR Shareholding
1st Dec 202210:01 amRNSTotal Voting Rights
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20228:54 amRNSDirector/PDMR Shareholding
7th Nov 20225:14 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 20223:55 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:01 amRNSTotal Voting Rights
23rd Sep 20223:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
6th Sep 20222:51 pmRNSDirector/PDMR Shareholding
2nd Sep 20223:16 pmRNSTotal Voting Rights
9th Aug 20229:20 amRNSDirector/PDMR Shareholding
1st Aug 202211:07 amRNSTotal Voting Rights
27th Jul 20224:08 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20228:12 amRNSDirector/PDMR Shareholding
1st Jul 20225:34 pmRNSTotal Voting Rights
29th Jun 202211:13 amRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSAcquisition of minority shareholding in Bordeaux
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
10th Jun 202211:43 amRNSBlocklisting Return
9th Jun 202212:11 pmRNSDirector/PDMR Shareholding
9th Jun 20227:36 amRNSIssue of Shares – Replacement
8th Jun 20223:52 pmRNSIssue of Ordinary Shares
6th Jun 20223:00 pmRNSPurchase of Ordinary Shares
1st Jun 202212:48 pmRNSTotal Voting Rights
27th May 20221:08 pmRNSAppointment of auditor
24th May 20222:12 pmRNSResult of AGM
23rd May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.